Cahill Represents ICON in $3.5 Billion Repricing of Credit Facilities

March 14, 2024

Cahill represented ICON plc and its subsidiaries in connection with a repricing amendment to their credit agreement to amend the terms of the $500 million revolving credit facility and provide for term B facilities in an aggregate principal amount of $2.976 billion.

Proceeds from the term B facilities were used to refinance Icon’s existing term loan credit facilities.

ICON is a contract research organization, providing outsourced services on a global basis to pharmaceutical, biotechnology, medical device, government, and public health organizations.